Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01PSK
|
|||
Drug Name |
PMID27841036-Compound-23
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Janssen Pharmaceutica NV
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H24N4O3
|
|||
Canonical SMILES |
CC(CC1=NC(=CC(=N1)OC)OC)(C#N)C2=CC3=C(C=C2)C4=C(CCCC4)C(=O)N3
|
|||
InChI |
1S/C23H24N4O3/c1-23(13-24,12-19-26-20(29-2)11-21(27-19)30-3)14-8-9-16-15-6-4-5-7-17(15)22(28)25-18(16)10-14/h8-11H,4-7,12H2,1-3H3,(H,25,28)
|
|||
InChIKey |
FITDTEZFVLDGBX-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Poly [ADP-ribose] polymerase (PARP) | Target Info | Inhibitor | [1] |
Target's Patent Info | Poly [ADP-ribose] polymerase (PARP) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | PARP inhibitors as antitumor agents: a patent update (2013-2015).Expert Opin Ther Pat. 2017 Mar;27(3):363-382. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.